Exelixis | EXEL - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
AstraZeneca USD 80M 7M 2026-06
Bayer EUR 169M 39M 2025-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Cytokinetics USD 11.02M 448K 2026-03
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Exelixis USD 14.21M 1.92M 2026-06
Genmab DKK 14M 11M 2026-03
Glaxosmithkline GBP 22M 4M 2026-03
Incyte USD 38.12M 4.43M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
MacroGenics USD 1.55M 26K 2026-03
Merck USD 35M 34M 2026-03
Moderna USD 72M 2M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD -0.04 115M 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Sanofi EUR 60M 54M 2026-03
Takeda JPY 24.61B 213.76B 2026-06
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Xencor USD 5.46M 741K 2026-03